• Title/Summary/Keyword: Heart development

Search Result 1,078, Processing Time 0.027 seconds

A Lingual Sound Analysis based on Oriental Medicine Auscultation for Heart Diseases Diagnosis (심장(心臟) 질환(疾患) 진단(診斷)을 위한 한의학적 청진(聽診) 기반의 설음(舌音) 분석)

  • Kim, Bong-Hyun;Cho, Dong-Uk;Her, Sung-Ho
    • The Journal of Korean Institute of Communications and Information Sciences
    • /
    • v.34 no.8B
    • /
    • pp.830-838
    • /
    • 2009
  • Oriental medicine lacks diagnosis data in fixed quantity possible to express visually to patients by depending on clinician's intuition than Western medicine that continues to development by various diagnosis devices. For that, this paper intends to examine relation between heart and voice signal regarded as center organ and source of life and mind in order to implement objectification through the visualization of oriental diagnosis method above all. According to because the heart is related to the tongue among five organs, by thinking with sounds, we would design the way of identifying existence of heart diseases focused on the fact that lingual sound pronunciation of heart patient is inexact. For this, we achieved a comparison, analysis of statistical bandwidth and morphological modeling of the second formants frequency about a lingual sound for their voice constituted subject group of heart diseases and normal people. Finally, we analyzed interrelationship to the result of experiment by designed method.

A study on the development and performance evaluation of reflective type Heart rate measurement system for PAPS (PAPS를 위한 반사형 맥파 측정 장치의 개발 및 성능 평가)

  • Kim, Sheen-Ja;Lee, Young-Woo
    • Journal of the Korea Institute of Information and Communication Engineering
    • /
    • v.16 no.1
    • /
    • pp.160-166
    • /
    • 2012
  • We performed the development and performance evaluation of reflective type heart rate measurement system for PAPS. We used chip LED and chip photo TR. for low power driving. The measured PPG signal is preprocessed using high pass filter and low pass filter, and the preprocessed signal is displayed by LabVIEW. Also LabVIEW include the algorithm that extract effective signal and calculate the heart rate. We made sure that it will be able to apply to measurement equipment with high accuracy and repetition from exercising subject using this system and algorithm.

Development of an Interventricular Pressure Measurement System or the Korean Total Artificial Heart (한국형 인공심장내의 심실간 압력 측정시스템의 개발)

  • Choi, S.W.;Ahn, J.M.;Jo, Y.H.;Om, K.S.;Min, B.G.
    • Proceedings of the KOSOMBE Conference
    • /
    • v.1997 no.11
    • /
    • pp.126-130
    • /
    • 1997
  • In the development of the totally implantable artificial heart (TAH), the information of the preload condition is important to ind appropriate condition or the automatic control of the heart. Our TAH configuration consists of two artificial ventricles, and brushless DC motor within actuator. The pressure between ventricles could indicate the preload condition during the TAH operation. If we can measure accurately inspite of the noise induced from TAH and environmental condition. We suggested integrating a feedback loop to remove an unexpected DC drift. NPI 19-series Nova sensor was used which could measure pressure in gas and liquid. This method and sensor enabled us to develop the pressure transducer compact so (that) the systems can be implanted with TAH into patient. This system has been verified in vitro and in vivo test. This results showed that the output waveform of this system was stable irrespective of animal condition.

  • PDF

Development and Evaluation of a Novel Electro-mechanical Implantable Ventricular Assist System (전기-기계식 이식형 좌심실 보조 시스템의 개발 및 평가)

  • 조한상;김원곤;이원용;곽승민;김삼성;김재기;김준택;류문호;류은숙
    • Journal of Biomedical Engineering Research
    • /
    • v.22 no.4
    • /
    • pp.349-358
    • /
    • 2001
  • A novel electro-mechanical implantable ventricular assist system is developed as a bridge to transplantation or recovery for patients with end-stage heart failure. The developed system is composed of an implanted blood pump, an external monitoring system which stores data, and a wearable system including a portable external driver and a portable power supply system. The blood pump is designed to be implanted into the left upper abdominal space and provides blood flow from the left ventricular apex to the aorta. The pulsatile blood flow is generated by a double cylindrical cam. There was mo excessive heat emission from the blood pump into the temperature-controlled chamber in the heat test and no stagnated flow within the blood sac by the observation in the flow visualization test. Animal experiments were performed using sheep and calves. The maximum assist flow rate reached 7.85L/min in the animal experiment. The evaluation results showed that the developed system was feasible for the implantable ventricular assist system. The long-term in vitro durability test and mid-term in vivo experiments are in progress and mow the modified next model is under development.

  • PDF

임상전단계의 완전 이식형 인공심장 시스템 개발

  • Min, Byeong-Gu;An, Jae-Mok;Park, Chan-Yeong;Jo, Yeong-Ho;Choi, Won-Woo;Kim, Hyeon-Jeong;Park, Seong-Geun;Lee, Jong-Jin;Choi, Jae-Sun;Eom, Gyeong-Sik;Kim, Jong-Won;Jang, Jun-Geun;Kim, Hui-Chan;Kim, Won-Gon;Won, Yong-Sun;No, Jun-Ryang
    • Proceedings of the KOSOMBE Conference
    • /
    • v.1996 no.11
    • /
    • pp.125-128
    • /
    • 1996
  • A new type of motor-driven total artificial heart system with a moving-actuator mechanism has been developed. The prototype system consists of a brushless do motor inside of actuator, two polyurethane sacs, and peripheral devices with internal controller. In this research work, the moving-actuator type electromechanical total artificial heart was redesigned for a good anatomical fitting. For total implantation we are developing the internal controller with high reliability and stability, and automatic control algorithm in response to the physiological requirements of animal. Contents and scope of the research work on ";Development of a totally implantable artificial heart of pre-clinical stage"; is summerized below 1) Animal experiment using sheep(55-60kg) 2) Development of implantable controller 3) Automatic control algorithm 4) Improvement of biocompatibility 5) Redesign of Actuator/blood pump.

  • PDF

Postprandial Lipemia, Genetics and CHD Risk

  • Ordovas, Jose M.
    • Nutritional Sciences
    • /
    • v.6 no.4
    • /
    • pp.229-231
    • /
    • 2003
  • New biochemical and genetic markers will be required to be more successful in the prevention of coronary heart disease. Postprandial lipid metabolism has received considerable attention since it was shown that postprandial triglyceride-rich lipoproteins are independently involved in the development of atherosclerosis. Multiple genes and environmental factors work in concert to alter these lipid. In this paper, postprandial lipemia, genetic variation and cardiovascular risk will be reviewed.

Developmental Changes of the Alpha1-Adrenergic System in the Rat Heart

  • 한형미
    • Proceedings of the Korean Society of Applied Pharmacology
    • /
    • 1993.11a
    • /
    • pp.25-27
    • /
    • 1993
  • The effect of alpha$_1$-adrenergic stimulation on cardiac automaticity changes during myocardial development. To illustrate, in isolated tissues from the mature canine heart, alpha$_1$-adrenergic stimulation usually induces a decrease in automatic rate. On the other hand, many early neonatal fibers exhibit an increase in automatic rate In response to alpha$_1$-agonists, which is not seen in the adult.

  • PDF

Development of CellML-based Simulation Platform for Cardiac Electromechanics

  • Marcellinus, Aroli;Lim, Ki-Moo
    • Proceeding of EDISON Challenge
    • /
    • 2017.03a
    • /
    • pp.625-627
    • /
    • 2017
  • Cardiovascular disease is the leading cause of death in America [1]. This kind of situation leads researcher to find out how to analyze the disease without using a living human heart. Computer simulation is the solution. Based on the existed clinical data and mathematical formulas from the journals, we can simulate a human heart activity using a computer. Moreover, we can also use the existed biological data in our simulation program, such as CellML (Cell Markup Language) [2].

  • PDF

Developmental Modulation of Specific Receptor for Atrial Natriuretic Peptide in the Rat Heart

  • Kim, Yoon-Ah;Kim, Soo-Mi;Kim, Suhn-Hee;Kim, Sung-Zoo
    • Animal cells and systems
    • /
    • v.6 no.3
    • /
    • pp.253-261
    • /
    • 2002
  • Although cardiac distribution of specific receptors for atrial natriuretic peptide (ANP) was mainly observed in the ventricular endocardium, the modulation of ANP receptors in relation to cardiac development is not defined. The present study was undertaken to investigate ANP receptor modulation in rat during development. In the developmental stages examined (fetus, after postnatal 3-days, 1-, 2-, 3-, 4-, and 8-week-old Sprague Dawley rats) specific ANP binding sites were localized in the right and left ventricular endo-cardia by quantitative in vitro receptor autoradiography using (equation omitted)-rat ANP as labeled ligand. The specific bindings to endocardium were much higher in the right than the left ventricle. The binding affinities of ANP were much higher in the right than the left ventricular endocardium. The difference of these binding affinities among various developmental stages was not observed in the right ventricle, whereas the binding affinity in left ventricle was gradually increased with aging and reached the peak value at 8 weeks. No significant difference in maximal binding capacities of endocardial bindings was observed in the right and left ventricular endocardia during developmental stages. Also, cGMP production via activation of particulate guanylyl cyclase-coupled receptor subtypes in the ventricular membranes was gradually decreased with close relationship to aging. Therefore, the present study show that the endocardial ANP receptor is modulated with close relationship to cardiac development in the left ventricle rather than the right ventricle, and may be involved in regulating myocardial contractility in left heart.

From Bench to Market: Preparing Human Pluripotent Stem Cells Derived Cardiomyocytes for Various Applications

  • Moon, Sung-Hwan;Bae, Daekyeong;Jung, Taek-Hee;Chung, Eun-Bin;Jeong, Young-Hoon;Park, Soon-Jung;Chung, Hyung-Min
    • International Journal of Stem Cells
    • /
    • v.10 no.1
    • /
    • pp.1-11
    • /
    • 2017
  • Human cardiomyocytes (CMs) cease to proliferate and remain terminally differentiated thereafter, when humans reach the mid-20s. Thus, any damages sustained by myocardium tissue are irreversible, and they require medical interventions to regain functionality. To date, new surgical procedures and drugs have been developed, albeit with limited success, to treat various heart diseases including myocardial infarction. Hence, there is a pressing need to develop more effective treatment methods to address the increasing mortality rate of the heart diseases. Functional CMs are not only an important in vitro cellular tool to model various types of heart diseases for drug development, but they are also a promising therapeutic agent for cell therapy. However, the limited proliferative capacity entails difficulties in acquiring functional CMs in the scale that is required for pathological studies and cell therapy development. Stem cells, human pluripotent stem cells (hPSCs) in particular, have been considered as an unlimited cellular source for providing functional CMs for various applications. Notable progress has already been made: the first clinical trials of hPSCs derived CMs (hPSC-CMs) for treating myocardial infarction was approved in 2015, and their potential use in disease modeling and drug discovery is being fully explored. This concise review gives an account of current development of differentiation, purification and maturation techniques for hPSC-CMs, and their application in cell therapy development and pharmaceutical industries will be discussed with the latest experimental evidence.